2014
DOI: 10.1371/journal.pone.0090709
|View full text |Cite
|
Sign up to set email alerts
|

Progressive Volume Loss and White Matter Degeneration in Cstb-Deficient Mice: A Diffusion Tensor and Longitudinal Volumetry MRI Study

Abstract: Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1, OMIM 254800) is an autosomal recessive disorder characterized by onset at the age of 6 to 16 years, incapacitating stimulus-sensitive myoclonus and tonic-clonic epileptic seizures. It is caused by mutations in the gene encoding cystatin B. Previously, widespread white matter changes and atrophy has been detected both in adult EPM1 patients and in 6-month-old cystatin B–deficient mice, a mouse model for the EPM1 disease. In order to elucidate the sp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
23
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 37 publications
(59 reference statements)
2
23
0
Order By: Relevance
“…Here we show similar effects in the hippocampus, as young early symptomatic (P30) Cstb KO mice contained fewer hippocampal granule cells and a tendency to atrophy of the septal hippocampus, with no changes at the hippocampal temporal region. In agreement, an age-dependent hippocampal volume 0 loss was reported in Cstb KO mice using in vivo magnetic resonance imaging (MRI) volumetry starting at 2 months of age and peaking at 6 46 . The differences observed in the initiation of hippocampal atrophy may be explained by the higher sensitivity of stereology based cell quantification methods when compared to MRI structural change assessment 47 .…”
Section: Early Symptomatic Cstb Ko Mice Exhibit Slight Atrophy Of Thesupporting
confidence: 69%
See 1 more Smart Citation
“…Here we show similar effects in the hippocampus, as young early symptomatic (P30) Cstb KO mice contained fewer hippocampal granule cells and a tendency to atrophy of the septal hippocampus, with no changes at the hippocampal temporal region. In agreement, an age-dependent hippocampal volume 0 loss was reported in Cstb KO mice using in vivo magnetic resonance imaging (MRI) volumetry starting at 2 months of age and peaking at 6 46 . The differences observed in the initiation of hippocampal atrophy may be explained by the higher sensitivity of stereology based cell quantification methods when compared to MRI structural change assessment 47 .…”
Section: Early Symptomatic Cstb Ko Mice Exhibit Slight Atrophy Of Thesupporting
confidence: 69%
“…Progressive loss of brain volume that affects different structures has been reported in patients with CSTB mutations 5,6,44,45 as well as in Cstb KO mice 3,10,11,46 . At early disease stages in Cstb KO mice, apoptosis of granule neurons 7 and atrophy 11 are most prevalent in the cerebellum.…”
Section: Early Symptomatic Cstb Ko Mice Exhibit Slight Atrophy Of Thementioning
confidence: 96%
“…In one study, higher VBA sensitivity over TBSS was demonstrated following improved registration. 14 In rodents, the use of TBSS to analyze DTI data [15][16][17][18][19][20][21][22] has been generally inconsistent and suboptimal with regard to the parametrization: the FA threshold, separating WM from gray matter, varies between the studies and the normalization strategy is often limited to the most representative subject (MRS). Moreover, no study has assessed the impact of the projection.…”
mentioning
confidence: 99%
“…The mouse model recapitulates the principal symptoms of EPM1, myoclonic seizures and progressive ataxia (Pennacchio et al, 1998). Pathological findings in Cstb −/− mice match those in the patients: the mice exhibit progressive loss in brain volume due to neuronal death and consequent white matter atrophy in the cerebrum and cerebellum (Tegelberg et al, 2012, Manninen et al, 2013, Manninen et al, 2014). The earliest pathological finding in Cstb −/− mice is striking microglial activation present at postnatal day 14 and preceding the onset of myoclonus and progressive neuronal degeneration from 1 month of age onwards (Tegelberg et al, 2012).…”
Section: Introductionmentioning
confidence: 57%